Last reviewed · How we verify

fascia iliaca compartment block

University of Minnesota · FDA-approved active Small molecule ✓ Verified May 2026 Quality 2/100

fascia iliaca compartment block is a Small molecule drug developed by University of Minnesota. It is currently FDA-approved.

A fascia iliaca compartment block is a type of regional anesthesia technique used to provide analgesia or anesthesia to the hip and thigh. This block affects the femoral, obturator, and lateral cutaneous nerves with a local anesthetic.

At a glance

Generic namefascia iliaca compartment block
SponsorUniversity of Minnesota
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about fascia iliaca compartment block

What is fascia iliaca compartment block?

fascia iliaca compartment block is a Small molecule drug developed by University of Minnesota.

Who makes fascia iliaca compartment block?

fascia iliaca compartment block is developed and marketed by University of Minnesota (see full University of Minnesota pipeline at /company/university-of-minnesota).

What development phase is fascia iliaca compartment block in?

fascia iliaca compartment block is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing